Antech Diagnostics, Inc.

Antech Diagnostics, Inc., a for-profit veterinary diagnostics company based in Fountain Valley, California, provides clinical pathology testing, diagnostic laboratory services, and veterinary diagnostic equipment to federal research agencies as a prime contractor on full-and-open federal procurements, with no SBA set-aside participation across its recent award footprint.

Antech operates almost exclusively as a prime (99% of awards), competing without set-aside designation against the broader market. The company's core capabilities center on veterinary diagnostic laboratory testing — complete blood counts, blood chemistry analysis, urinalysis, bone marrow aspirates, cerebral spinal fluid evaluation, and microbiology services — predominantly supporting non-human primate research programs at the National Institutes of Health. Representative prime work includes a $214,358 purchase order from the National Institute of Allergy and Infectious Diseases (NIAID) for diagnostic testing of non-human primate samples (January 2023), a $156,970.96 firm-fixed-price purchase order from NIAID for veterinary diagnostic laboratory testing (January 2022), and a $130,000 order from NIAID for clinical pathological evaluation of non-human primate blood and bodily fluid samples (February 2025). Antech also supplies veterinary diagnostic equipment — a $73,084.20 purchase order from the National Institute of Mental Health for a LOGIQ E R9 Vet Console with Color Wave Doppler (August 2026), a $33,808.25 order from U.S. Customs and Border Protection for veterinary x-ray equipment (September 2025), and a $20,000 order from the Smithsonian Institution for diagnostic laboratory services (June 2024).

Customer concentration is extreme and narrow. NIAID accounts for 20 awards and $1.4 million of the $2.6 million combined potential value — 54% by dollar and 28% by count — and covers 73% of all awards when grouped with other NIH components (Office of Logistics and Acquisition Operations, Office of the Director, NIAID DEA OA Acquisitions, and National Institute of Mental Health). The Department of the Army Medical Command is the second-ranked customer by potential value, holding a single-award Blanket Purchase Agreement with a $265,456.79 ceiling through September 30, 2027, for veterinary laboratory services supporting military working dogs and research animals. Beyond NIH and Army, Antech has served the Smithsonian Institution, U.S. Customs and Border Protection, and the National Eye Institute, but these relationships are marginal by volume and dollars. Recent activity has declined — six awards in 2022 and 2024 versus three in 2023 and 2025, with only two awards in 2026 — and only one award ($73 thousand) faces ultimate completion within the next twenty-four months, presenting minimal near-term recompete exposure but signaling a contracting pipeline under pressure.

The vendor holds a single named parent vehicle: the NIAID Professional, Scientific and Technical Support Services IDV, though the source does not specify task-order volume or dollar magnitude against it. Antech operates as a subsidiary of Heska Corporation, a manufacturer of goods, though the source does not detail Heska's role or shared service-delivery arrangements. Antech's sub footprint is negligible — one recorded sub award to Camris International, LLC, for pathology testing on a GLP toxicology study for HIV-1 vaccine candidates (January 2026) — indicating the vendor operates almost entirely on its own resources rather than through teaming or subcontract leverage. Award categorization centers on veterinary services (33 awards) and testing laboratories and services (25 awards), with reference laboratory testing dominating the PSC profile (56 awards). The company competes in a specialized, low-volume federal market driven by research continuity and technical specialization rather than large-scale procurement vehicles or set-aside programs.